Medicare billing address
CMS Medicare provider billing file
1250 S Cedar Crest BlvdSuite 300
Allentown, PA 18103
CMS public data · NPI 1952340978
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Talha F Nazir, MD
Specialty
Credential
MD
NPI
1952340978
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Talha F Nazir, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1250 S Cedar Crest BlvdCMS Doctors & Clinicians file
1250 S Cedar Crest BlvdIn the 2024 CMS provider billing file, this NPI had 4,688 Medicare beneficiaries and 9,063 total services. The average beneficiary age was 76, and the average HCC risk score was 1.9.
Total Medicare allowed amount
$301,092.32
Total Medicare payment amount
$224,634.04
Medicare beneficiaries
4,688
Total services
9,063
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
49%
CMS beneficiary-panel share
Atrial fibrillation
47%
CMS beneficiary-panel share
Chronic kidney disease
46%
CMS beneficiary-panel share
Heart failure
45%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 4,986 | $7.56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 656 | $27.77 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 466 | $18.89 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 448 | $23.33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 392 | $27.19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 270 | $34.47 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 257 | $23.32 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 256 | $92.06 |
| Programming of dual lead pacemaker system | 99 | $34.53 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 97 | $31.41 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1952340978. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 354 | 771.7 | $428,825.30 |
| 2 | Metoprolol Succinate | Metoprolol Succinate | 228 | 625.2 | $5,772.70 |
| 3 | Amiodarone Hcl | Amiodarone Hcl | 173 | 446.4 | $3,785.35 |
| 4 | Metoprolol Tartrate | Metoprolol Tartrate | 120 | 338.3 | $1,124.75 |
| 5 | Xarelto | Rivaroxaban | 88 | 202 | $108,593.38 |
| 6 | Flecainide Acetate | Flecainide Acetate | 85 | 232 | $3,487.80 |
| 7 | Atorvastatin Calcium | Atorvastatin Calcium | 68 | 197.1 | $1,167.14 |
| 8 | Furosemide | Furosemide | 68 | 191.3 | $348.62 |
| 9 | Dofetilide | Dofetilide | 64 | 186.7 | $20,606.47 |
| 10 | Lisinopril | Lisinopril | 64 | 175.7 | $387.50 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1999
Group/practice field
Lehigh Valley Physician Group
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Cardiovascular Disease (Cardiology).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.